M&A · Healthcare · Buyer's industry: Pharmaceutical Preparations
NextCure, Inc. to acquire Avere Therapeutics
Announced Jul 14, 2026 · Announced · Private target
Deal value—
Premium—To unaffected price
EV / Adj. EBITDA—
ConsiderationAll stock
Transaction
- Acquirer
- NextCure, Inc. (NXTC)
- Target
- Avere Therapeutics
- Buyer type
- Strategic
- Offer price per share
- —
- Enterprise value
- —
- Status
- Announced
Deal protections
Not disclosed for private-company acquisitions.
Advisors
- To the acquirer
- Tungsten Advisors
- To the target
- Wedbush
Classification
- Sector
- Healthcare
- Buyer's industry
- Pharmaceutical Preparations